ABSI

Absci Corporation · NASDAQ

Sector Health Technology
Industry Biotechnology
Website absci.com
Employees(FY) 193
ISIN US00091E1091

Performance

-18.75%

+9.93%

-30.63%

-14.08%

-28.81%

YTD

-2.29%

Profile

Absci Corporation operates as a generative AI drug creation company in the United States. Its integrated drug creation platform identifies novel drug targets and creates biotherapeutic candidates. The company was founded in 2011 and is headquartered in Vancouver, Washington.

Advanced Technical Analysis

Technical Analysis of ABSI 2024-12-20

The stock indicators reflect a predominantly bearish sentiment, with a Moving Average Score of 10 indicating strong downward momentum, an Oscillators Score of 40 suggesting a neutral stance, and a Technical Score of 25 reinforcing the overall bearish outlook. This combination signals caution for potential investors, as the prevailing trend appea...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of ABSI

Stock Rank

Recent News & Updates

2024-12-12 19:10
Absci highlights progress, updates across proprietary pipeline(Yahoo Finance)
2024-12-11 19:00
Absci Highlights Progress and Updates Across Proprietary Pipeline and Leading AI Platform at 2024 RandD Day(Globenewswire)
2024-12-11 19:00
Absci Highlights Progress and Updates Across Proprietary Pipeline and Leading AI Platform at 2024 R&D Day(Yahoo Finance)
2024-11-20 19:00
Absci to Participate in the 36th Annual Piper Sandler Healthcare Conference(Globenewswire)
2024-11-19 20:15
AI's Growing Role in Transforming Healthcare Delivers Innovations in Diagnostics, Patient Care(Prnewswire)
2024-11-12 13:07
Absci Corp (ABSI) Q3 2024 Earnings Call Highlights: Strategic Partnerships and Financial Challenges(Yahoo Finance)
2024-11-12 08:23
Q3 2024 Absci Corp Earnings Call(Yahoo Finance)
2024-11-11 19:50
Absci Corporation (ABSI) Reports Q3 Loss, Misses Revenue Estimates(Yahoo Finance)
2024-11-11 18:30
Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results(Globenewswire)
2024-11-10 18:15
Absci Corp (ABSI) Q3 2024 Earnings Report Preview: What to Look For(Yahoo Finance)
2024-11-06 19:00
Absci to Host R&D Day on December 12, 2024(Globenewswire)
2024-10-30 20:00
Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI(Globenewswire)
2024-10-23 20:00
Absci to Participate in Upcoming Investor Conferences(Globenewswire)
2024-10-14 20:00
Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024(Globenewswire)
2024-08-31 14:37
Absci Corporation (ABSI): A Penny Stock That Will Make You a Millionaire(Insider Monkey)
2024-08-31 02:37
Absci Corporation (ABSI): A Penny Stock That Will Make You a Millionaire(Insidermonkey)
2024-08-30 10:30
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought(Motley Fool)
2024-08-21 08:00
Absci to Participate in Upcoming Investor Conferences(GlobeNewswire)
2024-08-20 20:00
Absci to Participate in Upcoming Investor Conferences(Globenewswire)
2024-08-16 06:25
Absci Second Quarter 2024 Earnings: Misses Expectations(Simply Wall St.)
2024-08-14 16:01
Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results(GlobeNewswire)
2024-08-14 05:30
Absci Corporation (ABSI) Reports Q2 Loss, Lags Revenue Estimates(Yahoo Finance)
2024-08-14 04:01
Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results(Globenewswire)
2024-08-12 09:15
ImmunityBio (IBRX) Reports Q2 Loss, Lags Revenue Estimates(Zacks)
2024-08-12 08:36
Absci Teams Up with Memorial Sloan Kettering for AI-Driven Drug Discovery(MT Newswires)
2024-08-12 08:00
Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI(GlobeNewswire)
2024-08-11 20:00
Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI(Globenewswire)
2024-07-31 04:25
Why Is Absci Corporation (ABSI) Among the Best Micro Cap Stocks Right Now?(Insider Monkey)
2024-07-12 09:33
Entrada Therapeutics (TRDA) Moves 10.4% Higher: Will This Strength Last?(Zacks)
2024-07-11 09:38
KeyBanc Adjusts Price Target on Absci to $6 From $8, Maintains Overweight Rating(MT Newswires)

Page 1 of 7

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.